These results are in accordance with two recent reports focused on ALS and frontotemporal dementia (FTD)–related mutations in PFN1 and MAPT, respectively, which showed a connection between disrupted elements of the cytoskeleton and different aspects of N/C trafficking integrity (110, 111). The gene discussed is PFN1; the disease is amyotrophic lateral sclerosis.